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1. Whole-cell, high-threshold, voltage-dependent calcium currents (ICa) were enhanced in
acutely dissociated, capsaicin-sensitive dorsal root ganglion neurones from diabetic
Bio Bred/Worchester (BB/W) rats, compared with those from age-matched, non-diabetic
controls. The magnitude of the enhancement increased with the duration of diabetes, and
reached significance at diabetic durations of 6 months (diabetic: 6-3 + 0 4 nA; current
density (CD), 157 + 12 pA pF'; means + S.E.M., n= 9, P< 0 01; control: 3-9 + 0-6 nA; CD,
116 + 11 pA pF'; n = 18) and 8 months (diabetic: 7-6 + 0 4 nA; CD, 177 + 25 pA pFY;
n = 11, P < 0005; control: 5-1 + 0 5 nA; CD, 111 + 26 pA pF-'; n = 15). Low-threshold,
voltage-dependent Ica were also enhanced in neurones from animals diabetic for 8 months
(diabetic: 2-5 + 0 7 nA, n = 4, P< 0 05; control: 0'7 + 0 5 nA, n = 6).
2. The Ica enhancement was prevented by long-term treatment of diabetic animals with an
aldose reductase inhibitor (ARI; peak Ica at 6 months: 4-41 + 0-48 nA, n = 2; at 8 months:
4-32 + 0-60 nA, n = 9).
3. The Ica enhancement was not due to a shift in the voltage dependence of either the
current-voltage relationship or steady-state inactivation.
4. The L channel antagonist nifedipine and preferential N channel antagonist w-conotoxin
GVIA (w-CgTX) caused a greater inhibition of high-threshold Ica in diabetic neurones
compared with controls (nifedipine: control: 25 + 3%, n = 26; diabetic: 36 + 7 %, n = 11;
w-CgTX: control: 40 + 4%, n = 21; diabetic: 50 + 7%, n = 7). Diabetic neurones also
demonstrated a significantly greater residual current (2-44 + 0 34 nA, n = 7) in the presence
of both antagonists vs. controls (1-28 + 0 30 nA, n = 8, P< 0 05), suggesting that N-, L- and
additional non-N-, non-L-type high-threshold Ica were enhanced.
Diabetic neuropathy is the most common form of peripheral
neuropathy in the Western world, with metabolic, functional
and morphological changes in peripheral nerves documented
in both human and animal models of diabetes mellitus
(Behse, Buchtal & Carlsen, 1977; Brismar, 1983; Sima et al.
1988). Despite this, there is relatively little data on the
effect of diabetes on neuronal function at the cellular level.
Abnormalities described in peripheral nerves of animal and
human diabetics include decreased conduction velocity,
morphological changes such as axonal swelling, axo-glial
dysfunction, atrophy and nerve fibre loss (Sima & Brismar,
1985), and metabolic alterations such as decreased
myo-inositol tissue levels, decreased Na+,K+-ATPase activity,
and mitochondrial membrane dysfunction linked to the
production of sorbitol by the polyol pathway in response to
hyperglycaemia (Greene, Lattimer & Sima, 1988). Decreased
Na+,K+-ATPase activity has also been reported to occur in
both superior cervical and dorsal root ganglia (DRG)
(Green, King, Thomas & Baron, 1986), suggesting that
similar pathophysiological mechanisms may be operative in
autonomic neuropathy. Decreased myo-inositol levels have
been associated with decreased production of intracellular
second messengers such as inositol trisphosphate and
diacylglycerol (Greene et al. 1988). In both human and
animal studies, treatment with oral aldose reductase
inhibitors or dietary myo-inositol supplementation have
been shown to reverse some of these metabolic changes, and
improve the nerve conduction defect (Greene et al. 1988;
Sima et al. 1988; Sima, Prashar, Zhang, Chakrabarti &
Greene, 1990).
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Considerable evidence suggests that metabolic over-
stimulation by cytosolic calcium ([Ca2+]i) may contribute to
neuronal cell injury (Nicotera, Bellomo & Orrenius, 1992).
An important contribution to [Ca2+]i in excitable tissues is
made by the entry of external Ca2+ through voltage-
dependent calcium channels (Thayer & Miller, 1990). Indirect
evidence suggests that calcium signalling is abnormal in
cardiac myocytes (Nobe, Aomine, Arita, Ito & Takaki,
1990), vascular smooth muscle (Kamata, Miyata & Kasuya,
1988), and other tissues (Levy, Gavin & Sowers, 1994) from
diabetic animals. Therefore, the goal of the present study
was to examine directly whether calcium influx via voltage-
dependent calcium channels was altered in primary
afferent sensory neurones in diabetes mellitus, and to
evaluate the effect of an aldose reductase inhibitor on any
observed alteration in calcium influx. We utilized the
Bio Bred/Worchester (BB/W) rat, which developes an
immunologically mediated type of diabetes that has
morphological and metabolic characteristics similar to
human type I diabetes mellitus (Brismar, 1983).
These studies have been presented in preliminary form
(Hall, Mann & Wiley, 1993a).
METHODS
Animal model
Prior approval for these experiments was obtained from the
University of Michigan Committee on Use and Care of Animals
(Authorization no. 3593A(2)), according to NIH guidelines. Three
groups of male BB/W rats were used: (i) adult non-diabetic;
(ii) age-matched diabetic treated with daily insulin injection; and
(iii) diabetic treated with daily insulin injection and the aldose
reductase inhibitor (ARI) WAY 121,509 (courtesy of Wyeth-
Ayerst Research, Princeton, NJ, USA; 3 mg (kg body weight)-'
day-' by oral gavage starting one week after onset of diabetes).
Prediabetic and non-diabetes-prone animals were obtained from
the NIH-sponsored colony at the University of Massachusetts
(Worchester, MA, USA) and maintained at the Michigan Diabetes
Research and Training Center. After the onset of diabetes, as
determined by the onset of glucosuria during daily urine glucose
monitoring, ultralente insulin (0A4-3 0 i.u. day-' subcutaneous
injection; Novo Nordisk, Princeton, NJ, USA) was administered
to maintain hyperglycaemic blood glucose levels between 16 and
25 mmol F' (300-450 mg dl-') and prevent ketoacidosis. Body
weight, urinary glucose and ketone bodies were monitored daily
and the insulin dose titrated as described previously (Sima, 1983).
Blood glucose levels were monitored daily until the desired plasma
glucose levels were achieved, and monthly thereafter. Sciatic nerve
conduction velocity was measured on the day before animals were
killed (Sima et al. 1990).
Preparation of acutely dissociated DRG neurones
Isolated, acutely dissociated DRG neurones were aseptically
prepared from the three groups of rats outlined above using a
technique similar to that described previously (Gross, Wiley,
Ryan-Jastrow & Macdonald, 1990). Rats were killed by inhalation
of 100% CO2, the spinal column was removed, and the thoracic
and lumbar DRGs identified and extracted. The DRGs were
trimmed, minced, incubated with 2 ml 0 3% collagenase Type II
(Sigma) and 0-1% trypsin Type I (bovine; Sigma), then triturated
and centrifuged. Enzymes were prepared in minimal essential
medium (MEM; Gibco) supplemented with 16 mm NaHCO3 and
28 mm glucose (320 mosmol kg'). The isolated DRGs were
resuspended in supplemented MEM containing 10% horse serum
(Gibco) without nerve growth factor, and plated onto poly-L-
lysine-coated glass coverslips. The coverslips were incubated in
93% air-7% CO2 at 370C, and recordings performed at room
temperature between 1P5 to 7 h after plating.
Whole-cell voltage-clamp recordings
Voltage-clamp recordings using the whole-cell variant of the
patch-clamp technique (Hamill, Marty, Neher, Sakmann &
Sigworth, 1981) were made at room temperature with glass
recording patch pipettes (Fisher microhematocrit tubes; Fisher
Scientific, Pittsburgh, PA, USA). Electrode resistances were
1-2 MfQ, and seal resistances were greater than 1 Gil. The
external bath solution contained (mM): 5 CaCl2, 67 choline
chloride, 100 tetraethylammonium chloride, 5-6 glucose, 5-3 KCl,
10 Hepes and 0'8 MgCl2 (pH 7*3-7*4, 320-330 mosmol kg-').
Recording electrodes were filled with (mM): 140 CsCl, 10 Hepes,
10 EGTA, 5 MgATP and 0. 1 LiGTP (all reagents from Sigma). The
pH was adjusted to 7-2-7-3 with 1 M CsOH after addition of ATP
and GTP, and the final osmolality (280-290 mosmol kg-') was
adjusted to 10-15% below that of the external recording solution
using distilled water. The recording solution was kept on ice
throughout the experiment.
Drug preparation
w-Conotoxin GVIA (wl)-CgTX; 1 mm stock solution; Sigma) was
prepared with filtered distilled water, lyophilized in 10 #1 aliquots,
and stored at -20 'C. On the recording day, 1-10 /M w-CgTX was
prepared using external recording solution. Nifedipine (1-10 /SM)
in external solution was prepared on the recording day and kept
covered with aluminum foil to exclude light. Capsaicin stock
solution (10 mM; Sigma) in 95% ethanol was stored at 4 'C and
diluted to 0 1-1 /zM on the recording day. All drug solutions were
kept on ice throughout the experiment.
Experimental protocol
Phase-bright cells, 23-38 4um in diameter, were selected using a
micrometer in the microscope objective lens and depolarized with
voltage steps generated by the program CLAMPEX (pCLAMP;
Axon Instruments, Foster City, CA, USA). Currents were recorded
using an Axopatch 1B patch-clamp amplifier (Axon Instruments)
with an input resistance of 1-3 MLQ, filtered with a Bessel filter at
10 kHz (-3 dB), sampled at 20 kHz and stored on hard disk as
binary data files. Drugs prepared as described above were applied
to the isolated cells using pressure ejection (compressed air;
0 5 psi) from glass micropipettes with 10-40 um openings
positioned approximately 50 mm from the cell. The pipettes were
lowered into the bath immediately prior to a 2-5 s application of
drug. Two seconds after drug application, currents were evoked,
and the pipette removed from the bath. In neurones in which
currents could still be elicited following administration of w0-CgTX
and nifedipine, capsaicin (0-1-10 FuM) was applied to assess
capsaicin sensitivity (>10% reduction in maximum inward
current).
Analysis of current components
Several calcium current (ICa) components (T, N, L, P) have been
described in primary afferent (nodose and DRG) neurones (Fox,
Nowycky & Tsien, 1987; Llinas, Sugimori, Lin & Cherksey,
1989). The low-threshold T current (if present) was elicited by
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Table 1. Body weight, blood glucose values and nerve conduction velocities in control, diabetic
and ARI-treated diabetic BB/W rats
Body weight Blood glucose
n (g) (mmol F')
Nerve conduction
velocity (m s-')
4 months
Control
Diabetic
8 355-6 + 4X3
8 2989 +59**
6 months
Control 18 468-1 + 3-4
Diabetic 9 369-7 + 6.7**
ARI-treated diabetic 2 358 7 + 9.2*
8 months
Control 15 489-2 + 2-8
Diabetic 11 382-7 + 6.8**
ARI-treated diabetic 9 378.9 + 7.3**
7 07 + 0-19
22-47 + 0-38**
5-74 + 018
21P21 + 0 73**
22-04 + 0.40**
5 9 + 0419
22-29 + 0 53**
21415 + 0-19**
*P< 0 005, ** P< 0 001 by ANOVA.
depolarizing the cell from holding potentials (Vh) of -80 or
-90 mV to clamp potentials (V,.) of -60 to -30 mV. High-
threshold currents were evoked by 100 ms depolarizations to a V,
of +10 mV at 1 min intervals with the cell alternately held at a Vh
of -80 mV and -40 mV. Current records were analysed with the
program CLAMPAN (pCLAMP; Axon Instruments). Leak
currents assessed by hyperpolarizing commands of equal value to
those used to depolarize the cell were digitally subtracted from Ica
To control for the possibility that alterations in Ica between the
control and diabetic groups occurred simply on the basis of
variations in cell size, the current density (CD; in picoamps per
picofarad) was determined. Small depolarizing calibration
voltage pulses (V, = +5 mV for 12 ms, or -10 mV for 100 ms;
Vh = -80 mV) were performed immediately after patch rupture.
Whole-cell capacitance (proportional to surface area) was
calculated using the following formula:
AC=
'
V'
where C is capacitance (in picofarads), A (in picofarads per
millivolt) is the area under the capacitance current curve from the
peak inward current to the point at which ICa is 0, and V is
calibration voltage step (in millivolts). Peak inward currents were
divided by the cell capacitance, and the normalized currents
expressed in units of picoamps per picofarad.
Current-voltage curve normalization
Current-voltage (I-V) curves were generated by depolarizing
neurones from a Vh of -80 mV to a VE of -110 to +90 mV in
10 mV steps (100 ms duration). The peak inward current for each
depolarization step was plotted as a function of V,. The baseline
was determined by a least-squares fit of the line connecting the
points from -110 to -60 mV, and this line subtracted from the
data points at each voltage step to create a baseline-subtracted
I-V curve. The curves were averaged to produce mean + S.E.M.
values at each Vc for control, diabetic and ARI-treated diabetic
neurones.
Assessment of voltage dependence of steady-state
inactivation
Cells were depolarized to a V, of +10 mV for 100 ms from
progressively more positive Vh (-90 to 0 mV by 10 mV steps). The
cell was held at each Vh for 15 s prior to depolarization. Peak
current amplitude at each Vh was plotted as a function of Vh, and
fitted with a Boltzman curve generated with the following
formula:
istep 1
'max 1 + exp((Vm- Vh)/l)
where 'Step is peak inward current at holding potential Vh, 'max i
the maximum peak inward current elicited, 7h is holding potential
in millivolts, Vm is the voltage at which half-maximal inactivation
occurred, and k is the slope.
Statistical analysis
Significance was determined using analysis of variance and
Student's two-tailed t test, and defined as a P value less than 0 05
(Mendenhall, 1975). Results are given as means + S.E.M.
RESULTS
BB/W rat body weights, hyperglyeaemia and nerve
conduction velocities
Prediabetic BB/W rats developed diabetes at a mean age of
74 + 3 days. Body weight gain was significantly decreased
in diabetic rats (non-treated and ARI-treated) at all time
points compared with that of non-diabetic control rats
(Table 1).
Blood glucose values were elevated above 20 mmol 1-' in all
diabetic rats, and ARI treatment had no effect on blood
glucose levels (Table 1). Compared with control animals,
diabetic rats developed significant functional neuropathy as
reflected by slowing of sciatic nerve conduction velocity,
which was ameliorated following ARI treatment (Table 1).
Calcium currents in DRGs from diabetic and control
animals
Whole-cell voltage-dependent ICa were elicited in DRGs
between 23 to 38 ,um in diameter (control: 29 + 3 ,sm,
n = 25; diabetic: 30 + 4 /sm, n = 17), by depolarization to
a V, of +10 mV from a Vh of -80 alternating with -40 mV
at 1 min intervals (Fig. 1).
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Figure 1. Diabetes mellitus increased high-threshold calcium currents in BB/W rat DRGs
A, the maximum amplitude of the inward current elicited by depolarization to +10 mV from a Vh of
-80 mV (circles) and -40 mV (squares) plotted vs. time from patch rupture in minutes for a diabetic
neuron (filled symbols) and a control neuron (open symbols). B, current tracings corresponding to the
numbered points in A. C, run-down of current in control (0) and diabetic (o) neurons is shown as the
mean + S.E.M. of Ic./peak ICa plotted vs. time from peak ICa*
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Figure 2. Enhancement of calcium currents in diabetes was prevented by an aldose reductase
inhibitor
A, means + S.E.M. of currents elicited by depolarization to +10 mV from a Vh of -80 mV in neurones from
control (L), diabetic (U) and ARI-treated diabetic () animals (diabetic duration 4 months: 8 control,
8 diabetic neurones; diabetic 6 months: 18 control, 9 diabetic, 2 ARI-treated diabetic neurones; diabetic
8 months: 15 control, 11 diabetic, 9 ARI-treated diabetic neurones; ***P< 0005, ** P < 001 by
ANOVA). B, I-V curves and C, steady-state inactivation curves generated as described in Methods for
10 control (0), 10 diabetic (o), and 11 ARI-treated (N, B only) neurones.
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Table 2. Diabetes mellitus associated with enhanced calcium current density (CD) in rat DRGs
Vh = -80 mV Vh =-40 mV
Diameter Capacitance
n (um) (pF)
Peak Ica
(nA)
CD Peak Ica CD
(pA pF') (nA) (pA pF')
8 28+2 24'9+331 2-7+0 8 98+12 1P6+0-4 85+24
7 27+3 32-4+0 8 3'2+007 108+14 1 9+0-8 85+19
17 26+2 22-4+225 2-4+003 116+11 1P8+0-3 110+10
9 25+2 19'7+331 49+04** 157+12* 3.1 +03* 101 +14
14 34+4 39-1 +4-2 4-3+003 111 +26 3'1 +04 75+12
10 36+3 43-8+446 6-2+0-3***177+25** 4.8+0-4** 115+12*
***P< 0005, ** P< 001, * P< 0-05 by ANOVA.
High-threshold voltage-dependent currents (N-, L-type)
were observed in all cells; however, low-threshold voltage-
dependent currents (T-type) were detected in only 8% of
neurones. Following patch rupture, the maximum amplitude
of high-threshold ICa increased during the initial 2-5 min,
after which run-down of the current was observed in both
diabetic and control neurones (Fig. 1A). In Fig. lB the
current traces corresponding to the numbered points in
Fig. 1A are shown. There was no significant difference in
the leak conductance measured in control vs. diabetic
neurones (control, 68 + 44 pA; diabetic, 87 + 32 pA). The
time course of current run-down was similar in diabetic
and control neurones (Fig. 1C). Approximately 80% of
both control and diabetic neurones in the size range
evaluated were responsive to capsaicin, as defined by a
>10% decrease in current amplitude to capsaicin.
Application of capsaicin (0-1 /M) decreased currents by
58 + 9% in control neurones (n= 12) and 44 + 13% in
diabetic neurones (n = 11, no significant difference). Data
from both capsaicin-sensitive and -insensitive neurones
were combined for subsequent analysis.
Enhanced calcium currents observed in diabetes
Diabetes mellitus was associated with an increase in the
peak of the voltage-dependent ICa evoked from a Vh of
-80 mV at a VI of +10 mV (Fig. 2A).
The magnitude of the enhancement increased with the
duration of diabetes, and reached significance at diabetic
durations of 6 months (control: 3-9 + 0-6 nA, n = 18;
diabetic: 6-33 + 0-41 nA, n = 9, P< 001) and 8 months
(control: 5*1 + 0*5 nA, n = 15; diabetic: 7-59 + 0-38 nA,
n = 11, P< 0 005). To control for cell size, the CD for each
cell was calculated by dividing ICa elicited by depolarization
to a V, of +10 mV by the whole-cell capacitance as described
in Methods.
Enhancement of CD was observed at 6 months of diabetes
in neurones held at a Vh of -80 mV, and at both Vh values
of - 40 and -80 mV in neurones from animals diabetic for
8 months (Table 2).
Enhancement of voltage-dependent calcium currents
in diabetes mellitus was prevented by long-term
treatment with an aldose reductase inhibitor
Diabetic rats treated with oral WAY 121,509 (3 mg kg-)
as described in Methods did not exhibit enhancement of
high-threshold DRG ICa compared with age-matched, non-
diabetic controls (Fig. 2A). Peak high-threshold ICa elicited
by depolarization to +10 mV from a Vh of -80 mV at
6 months of diabetes was 4'41 + 0-48 nA (n = 2), and at
8 months was 4-32 + 0'60 nA (n = 9), values that were not
significantly different from I.. recorded from age-matched,
non-diabetic control DRGs. The degree of hyperglycaemia
in the present study was comparable in the untreated
diabetic and ARI-treated diabetic groups (Table 1). The
mean cell diameters of ARI-treated neurones at 6 and
8 months were 25 + 2 and 34 3 sum, respectively; values
not significantly different from those in control and diabetic
neurones in the same age ranges (Table 2).
Diabetes mellitus was not associated with a shift in
the current-voltage relationship
Diabetic neurones did not exibit any shift in the I-V
relationship compared with control neurones (Fig. 2B). The
peak of the I-V curve was shifted +10 mV more positive
in ARI-treated neurones compared with both control and
diabetic cells; however, this shift was by the same amount
as the test interval. To determine whether a true shift was
present, a subset of cells had I-V curves generated by
depolarization from -20 to +20 mV at 5 mV intervals
(6 control, 5 diabetic, 4 ARI-treated). At +5 mV intervals,
the peak current in control, diabetic and ARI-treated cells
occurred at a Vc of +10 mV, and therefore the 10 mV shift
between the curves was deemed to be an artifact of the
sampling interval.
4 months
Control
Diabetic
6 months
Control
Diabetic
8 months
Control
Diabetic
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Diabetes did not change the voltage dependence of
steady-state inactivation
Steady-state inactivation curves were generated as
described in Methods and averaged for control and diabetic
neurones (Fig. 2C). The average curves were fitted with a
Boltzman equation as described in Methods, with values for
Vm and k of -30 07 and 14-29 mV for the control curve,
and -29-18 and 13-94 mV for the diabetic curve,
respectively. There was no significant shift in the voltage
dependence of steady-state inactivation in diabetic
neurones compared with controls.
Diabetes mellitus was associated with enhancement
of N, L, and non-N, non-L calcium currents
We hypothesized that if diabetes preferentially enhanced
only the N-type current, then the ratio of the peak current
amplitudes elicited by depolarizing diabetic DRGs to
+10 mV from a Vh of -40 mV vs. -80 mV (-40: -80 ratio)
would be less than that observed in controls, due to
inactivation of the N-type, high-threshold ICa at more
positive Vh (Fox et al. 1987). However, comparison of the
-40:-80 ratio at increasing duration of diabetes did not
demonstrate any significant difference between control,
diabetic and ARI-treated diabetic neurones, and therefore
the observed enhancement in whole-cell ICa in 6 and
8 month diabetic neurones was unlikely to be due to an
enhancement in N-type current alone. To elucidate the
contribution of N- and L-type currents to the observed
increase in ICa' we evaluated the effect of the L-type
channel antagonist nifedipine (3/uM) and the N-type
channel antagonist w-CgTX (10 ,UM) on ICa in diabetic and
control DRGs by applying these antagonists during the
current run-down phase. Antagonists were applied for 2 s
A
Control
-30 mV,
-80
1 nA L
20 n
Diabetic
_- -L
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by pressure ejection from micropipettes placed close to the
neurone (see Methods). Application of diluent alone had no
effect on the ICa amplitude. The agonist concentrations used
were close to, or at the maximum level of, the published
dose-response (Fox et al. 1987), and our previous studies
(Hall et al. 1993a) suggested that the concentrations of
nifedipine and w-CgTX employed in these studies
produced near-maximal antagonism of the L- and N-type
Ica, respectively. Prior to application of nifedipine,
neurones were held at -40 mV to enhance voltage-
dependent inactivation of N-type channels and thereby
increase the relative contribution from L-type channels to
the total evoked current. Nifedipine reduced I.a elicited by
depolarization to +10 mV for 100 ms from a Vh of -40 mV
by 25+3% in control DRGs (n= 25) and 36+7% in
diabetic DRGs (n = 11). w-CgTX reduced currents evoked
by depolarization to +10 mV from a Vh of -80 mV by
40 +4% in control DRGs (n=21) and by 50+7% in
diabetic DRGs (n = 7). In the presence of both antagonists,
a residual current could be elicited by depolarization to a VIK
of +10 mV from a Vh of -80 mV, which was significantly
larger in diabetic neurones (2-44 + 0 34 nA, n = 7) than
controls (1-28 + 0 30 nA, n = 8, P< 0 05). The percentage
reduction in current due to either antagonist was greater in
diabetic neurones, suggesting that the enhancement
observed in diabetic DRG Ic. involved both N- and L-type
currents. In addition, the significantly larger residual
current observed in diabetic neurones when N- and L-type
antagonists were administered concurrently suggested that
diabetes was associated with enhancement of additional
non-N-, L-type, high-threshold, voltage-dependent ICa
described in various neuronal tissues (Llinas et al. 1989).
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Figure 3. Diabetes-enhanced low-threshold (T-type) calcium current
A, representative transient (T-type) ICa elicited by depolarization to -30 mV from a Vh of -80 mV in a
control and diabetic neurone. B, peak T currents (means + S.E.M.) in DRGs from 4 diabetic and 6 control
animals aged 8-10 months (*P 0 05). C, I-V relationship of neurones that expressed T currents. I-V
curves were generated as described in Methods for neurones demonstrating T currents (location of peak
T currents denoted by horizontal bar).
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Effect of diabetes on low-threshold (T-type) calcium
currents
Approximately 8% of neurones demonstrated transient
low-threshold ICa that activated and inactivated rapidly
when elicited by depolarization to -30 mV from a Vh of
-80 mV (Fig. 3A). These currents were inactivated when
the neuron was held at -40 mV, and correspond to the
T-type current described previously (Fox et al. 1987).
The average magnitude of the peak T current (Fig. 3B) was
significantly greater in diabetic neurones (2-5 + 0 7 nA,
n= 4) compared with controls (0 7 + 0'5 nA, n = 6).
Analysis of the I-V relationship of cells that expressed
T currents (Fig. 3C) did not demonstrate any shift in the
voltage dependence of the peak low-threshold ICa (location
denoted by horizontal bar) in diabetic neurones compared
with controls.
DISCUSSION
High-threshold, voltage-dependent calcium currents
were enhanced in acutely dissociated nociceptive
DRGs from diabetic rats
We hypothesized that small- to medium-sized (20-38 ,um),
capsaicin-sensitive DRGs would show abnormalities early
in diabetes, as there is evidence for early and preferential
loss of small, unmyelinated, nociceptive nerve fibres and
their corresponding cell bodies in diabetes (Sima & Brismar,
1985). In our study, approximately 80% of DRG neurones,
23-38 jum in diameter, were responsive to capsaicin 0 1 /LM
(>10% decrease in peak ICa), and thus the majority of
neurones recorded were probably of nociceptive origin.
Isolated, acutely dissociated DRG neurones in this size
range demonstrated characteristic low- and high-threshold
voltage-dependent ICa (Fox et al. 1987; Llinas et al. 1989),
which were enhanced in DRGs from diabetic BB/W rats
compared with age-matched controls. The magnitude of
enhancement increased with the duration of diabetes, and
was not observed in diabetic animals receiving long-term
treatment with the aldose reductase inhibitor WAY
121,509. The increase in ICa was not due to a bias towards
recording from larger neurones in the diabetic group, since
the mean cell diameter of non-diabetic and diabetic
neurones was not significantly different. Current density
measurements, which correct for cell size by dividing the
whole-cell current by the cell capacitance (proportional to
cell surface area), were also significantly higher in neurones
from diabetic animals at 6 and 8 months.
The voltage dependence of the current-voltage
relationship and steady-state inactivation were not
altered in diabetes
Alterations in current amplitude in response to
noradrenaline, opiates and protein kinase A (PKA) have
been correlated with shifts in the voltage dependence of
activation (Bean, 1989; Doupnik & Pun, 1992) and
inactivation (Gross & Macdonald, 1989), and therefore
possible explanations for the enhanced amplitude of
currents in diabetic neurones could be shifts in either the
voltage dependence of the peak current towards more
negative potentials, or inactivation towards more positive
potentials. However, there was no significant shift in the
voltage dependence of either the I-V relationship, or
steady-state inactivation of currents in diabetic neurones
compared with controls. Increased expression of functional
calcium channels could underlie the observed enhancement,
as could other potential mechanisms operating at the
single-channel level, such as increased conductance,
opening frequency or duration.
Multiple high-threshold calcium currents were
enhanced in diabetes mellitus
Several results in this study suggest that multiple high-
threshold 'Ca were enhanced in neurones from diabetic
animals. Currents elicited at more positive holding
potentials ( Vh = -40 mV) contain proportionately less
rapidly inactivating N-type Ica, and proportionately
more slowly inactivating L-type current (Fox et al. 1987)
than currents elicited from more negative potentials
(Vh =-80 mV). If the N- or L-type current were
preferentially enhanced by diabetes, the ratio of the high-
threshold currents elicited by depolarization from Vh of
-40: -80 would probably be altered with longer durations
of diabetes. Although there was a trend towards a decreased
ratio at 8 months in the diabetic group (suggesting either
increased L- or decreased N-type current), this was not
significant. Therefore, more than one type of current
appeared to be affected. The CD at 6 months of diabetes,
was significantly larger only at a Vh of -80 mV, but by
8 months, current densities elicited by depolarization from
Vh values of both -80 and -40 mV were significantly
enhanced in diabetic neurones. This result could indicate
that: (i) diabetes increased the more rapidly inactivating
(N-type) current, and that the significant current
enhancement observed by 8 months at a Vh of -40 mV
could have been due to a component of a large residual N-
type current that was not completely inactivated at this Vh,
or (ii) initially only the N-type current was enhanced at
6 months, and with increasing diabetic duration to
8 months, N-type and other high-threshold currents were
enhanced. However, using voltage criteria alone, it is not
possible to unequivocally separate the current components;
therefore, we employed pharmacological antagonists. The
N-type channel antagonist w-CgTX and the L-type
antagonist nifedipine both decreased currents by a greater
percentage in DRGs from 6 and 8 month diabetic animals.
Despite the larger percentage reduction of current, the
absolute magnitude of the remaining current after
antagonist application was significantly larger in diabetic
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neurons, indicating that diabetes enhanced at least N- and
L-type ICa. Additionally, in the presence of both
antagonists, the residual current was significantly larger in
diabetic DRGs, suggesting that enhancement of additional
high-threshold currents (Llinas et al. 1989) may occur in
diabetes mellitus. Low-threshold rapidly inactivating (T-
type) currents were also significantly larger in diabetic cells.
The observation that multiple ICa types were affected,
suggests that diabetes mellitus may alter an intracellular
pathway that regulates multiple calcium channels.
Treatment with aldose reductase inhibitor prevented
calcium current enhancement in diabetes
In previous human and animal studies, ARI treatment has
been shown to improve nerve conduction defects, and
normalize myo-inositol and Na+,K+-ATPase levels in
diabetes (Sima et al. 1990). In this study, chronic oral
treatment with the aldose reductase inhibitor WAY 121,509
initiated 1 week after onset of diabetes prevented the Ica
enhancement observed in neurones from untreated diabetic
animals. This effect was observed in neurones from animals
with moderate to long duration of diabetes, suggesting that
long-term ARI treatment may be of benefit in disease of
long-standing duration. The decreased currents in ARI-
treated animals were not due to decreased availability of
glucose, as the level of hyperglycaemia was comparable in
the diabetic and ARI-treated groups. In the hyper-
glycaemic state, aldose reductase converts a significant
amount of glucose into sorbitol (Greene et al. 1988).
Accumulation of sorbitol produced by the polyol pathway
in response to hyperglycaemia has been implicated as a
cause of the decreased myo-inositol and Na+,K+-ATPase
levels described previously in sciatic nerves from diabetic
rats (Das, Bray, Aguayo & Rasminsky, 1976; Greene et al.
1988). Decreased myo-inositol uptake in diabetes has been
linked to decreased production of inositol trisphosphate
(Green et al. 1988), diacylglycerol (Zhu & Eichberg, 1990),
and protein kinase C (PKC; Kim, Rushovich, Thomas,
Uedat, Agranoff & Greene, 1991).
Putative mechanisms underlying enhanced calcium
currents in diabetes
One mechanism that could underly the increase in ICa
observed in this study is altered phosphorylation of
voltage-dependent calcium channels by protein kinases
such as PKC or PKA. Phorbol esters, which activate
endogenous PKC, have been reported both to decrease and
enhance high-threshold ICa (Gross & Macdonald, 1989;
Yang & Tsien, 1993). This discrepancy may be due to
differences in endogenous PKC levels and/or activity
between tissue types. Alternatively, phorbol esters may
have non-specific effects independent of their action to
activate PKC (Hockberger, Toselli, Swandulla & Lux,
1989). Direct application of constitutively active PKC
causes enhancement of 'Ca in DRGs (Hall, Tan, Browning
& Macdonald, 1993 b) and invertebrate tissues (DeRiemer,
Strong, Albert, Greengard & Kaczmarek, 1985). Decreased
cytosolic PKC levels have been described in diabetic
neurones (Kim et al. 1991); however, in other tissues,
increased PKC activity has been documented (Tanaka et al.
1991). One possible explanation for these discrepancies in
PKC activity may lie in the recent demonstration of
selective activation of PKC isoforms in diabetes (Inoguchi,
Battan, Handler, Spotsman, Heath & King, 1992; Tang,
Parker, Beattie & Houslay, 1993). Alternatively, alterations
in other components of signal transduction that affect
calcium channel function, such as guanine nucleotide-
binding (G) proteins, may be present in diabetes. Houslay
and colleagues (Gawler, Milligan, Spiegel, Unson & Houslay,
1987; Bushfield et al. 1990) have described decreased
levels and functional activity of inhibitory G proteins in
hepatocytes from diabetic rats. Of interest, enhancement of
Ica in pancreatic and pituitary cell lines by exposure to
serum from diabetic patients has been reported recently
(Juntti-Berggren et al. 1993). These authors concluded that
a protein in the IgM fraction of serum was responsible for
the observed enhancement. Therefore, circulating factors in
diabetic serum may also contribute to increased calcium
influx in diabetes.
In conclusion, we observed an enhancement in multiple
high-threshold, voltage-dependent Ica in capsaicin-sensitive
DRG neurones in diabetic BB/W rats compared with age-
matched, non-diabetic controls, suggesting that alteration
of a common pathway, involving either the expression of
functional calcium channels or their regulation, occurs in
diabetes mellitus. As altered calcium homeostasis resulting
in elevation of [Ca2+]i may contribute to neuronal cell
injury and death (Nicotera et al. 1992), enhanced calcium
influx may contribute to impairment of neuronal function
in diabetes mellitus. Finally, a recent study demonstrated a
beneficial effect of the L-type calcium channel antagonist
nimodipine on streptozotocin-induced diabetic neuropathy
in the rat (Kappelle, Biessels, Bravenboer, van Buren,
Traber, de Wildt & Gispen, 1994), suggesting that
abnormalities in cellular calcium influx in diabetes mellitus
may provide possible new targets for treatment.
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